PIN23 Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan

Simple item page
dc.contributor.authorAlmadiyeva, A.
dc.contributor.authorIbrayev, S.
dc.contributor.authorTurgambayeva, A.
dc.contributor.authorNurgozhin, T.
dc.creatorA., Almadiyeva
dc.date.accessioned2017-12-14T05:51:58Z
dc.date.available2017-12-14T05:51:58Z
dc.date.issued2016-11-01
dc.identifierDOI:10.1016/j.jval.2016.08.144
dc.identifier.citationA Almadiyeva, S Ibrayev, A Turgambayeva, T Nurgozhin, PIN23 - Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan, In Value in Health, Volume 19, Issue 7, 2016, Pages A911-A912
dc.identifier.issn10983015
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1098301516307240
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/2892
dc.relation.ispartofValue in Health
dc.rights.licenseCopyright © 2016 Published by Elsevier Inc.
dc.titlePIN23 Economic Evaluation of Protease Inhibitors for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Kazakhstan
dc.typeArticle
dcterms.provenanceValue in Health
elsevier.aggregationtypeJournal
elsevier.coverdate2016-11-01
elsevier.coverdisplaydateNovember 2016
elsevier.endingpageA912
elsevier.identifier.doi10.1016/j.jval.2016.08.144
elsevier.identifier.eid1-s2.0-S1098301516307240
elsevier.identifier.piiS1098-3015(16)30724-0
elsevier.issue.identifier7
elsevier.openaccess1
elsevier.openaccessarticletrue
elsevier.openaccessuserlicensehttp://www.elsevier.com/open-access/userlicense/1.0/
elsevier.openarchivearticletrue
elsevier.startingpageA911
elsevier.volume19

Files

Collections

Center for Life Sciences